Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Retrospective-Prospective Study on CLL Therapy Approaches in Russia.

NCT05140369 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05140369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05140369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Retrospective-Prospective Study on CLL Therapy Approaches in Russia.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
October 29, 2021
Completion date
March 31, 2027
Enrollment
6,000 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia